Apjohn Ventures

Apjohn Ventures Fund operates as a venture capital firm, primarily focused on making early-stage equity investments in innovative life sciences companies. The firm targets businesses specializing in biotech, medical devices, R&D tools, and general healthcare, predominantly across the Midwest and extending to the East Coast. They aim to provide capital alongside strategic guidance, leveraging their profound industry knowledge and expansive networks to foster growth and development within their portfolio companies.

The firm was founded by Mina Patel Sooch and Donald R. Parfet. Together, they bring over four decades of experience spanning pharmaceutical and healthcare management, finance, and business development. Their insight stemmed from recognizing a critical need for specialized venture funding within the burgeoning life sciences sector of the Midwest, with the firm’s name, Apjohn, honoring the legacy of pioneering pharmaceutical entrepreneur Dr. William E. Upjohn.

Apjohn Ventures partners with scientists and entrepreneurs, assisting them in transforming novel concepts into thriving life sciences enterprises. The firm’s vision centers on generating high-value companies that advance medical solutions, ultimately contributing to improved human health outcomes. They aspire to support companies that develop innovative therapies and technologies, thereby helping individuals live longer and better lives.